Skip to main content

Table 4 Changes measured by OCT and ICGA in eyes that received PDT at the 12-month follow-up

From: Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy

Number of eyes (%) Morphological changes
9 (56.3%) Subretinal fluids absorbed
8 (53.3%) PED resolved
11 (61.6%) Complete regression of polyps
3 (16.7%) Reduction in polyps
  1. OCT optical coherence tomography, ICGA indocyanine green angiography, PDT photodynamic therapy, PED pigment epithelial detachment